Summary &horbar; An in vitro system for the incubation of mediobasal hypothalami (MBH) of cockerels and a radioimmunoassay for chicken luteinising hormone-releasing hormone-I (cLHRH-1) were developed. The size of the hypothalamic fragment (MBH including the median eminence) and the incubation conditions used (40°C, under constant shaking and gassing) preserved the physiological properties of the tissue. It was possible to maintain the MBH in vitro and to study the LHRH release for several hours. The assay proved sensitive enough (ED BO = 0.794 pmol/tube, ie 4.59 pg/ml) and sufficiently precise (within-assay coefficient of variation = 4.4% and between-assay coefficient of variation = 10.2%) to measure the amounts of peptide released in the incubation medium. The use of this incubation system provided the first evidence of the stimulating effect of the excitatory amino acids glutamate, NMDA and kainate on the secretion of cLHRH-1 in birds. Our results suggest that the effect on the NMDA receptor is predominant. 
INTRODUCTION
The release of luteinising hormone-releasing hormone (LHRH) by hypothalamic neuron terminals at the level of the median eminence is one of the major regulating steps of reproductive function and the direct measurement of the secretion of LHRH is required for the understanding of reproductive physiology. Thus, several in vivo (Levine and Ramirez, 1986 , in the rat; Caraty and Locatelli, 1988 , in the ram) and in vitro (review in Wibullaksanakul and Handelsman, 1991 ) techniques have been developed. The in vitro approach has the advantage of allowing the direct testing of the effect of various substances on the secretion. Two types of in vitro methods have been described: superfusion (Gallardo and Ramirez, 1977 , in the rat; Knight, 1983 , in the chicken) and static incubation (Rotsztejn et al, 1976 , in the rat; Katz et al, 1990 , in the chicken). Wibullaksanakul and Handelsman (1991) compared both systems in a systematic study and concluded the superiority of static incubation, which they judge technically simpler, more robust and accurate than superfusion. With the aim of studying the regulation of LHRH secretion in the chicken, we have developed an incubation system for chicken mediobasal hypothalamus (MBH) and a radioimmunoassay sensitive enough for reliable measurement of the amounts of chicken LHRH-I released in vitro. Indeed, from the 2 forms of LHRH known in the chicken, chicken LHRH-1 (cLHRH-1) (King and Millar, 1982a,b) and chicken LHRH-11 (cLHRH-II) (Miyamoto et al, 1984) , only cLHRH-I has been shown to be released from the median eminence (Katz et aI, 1990 (Sterling and Sharp, 1982; J6zsa and Mess, 1982) . The cLHRH-11 cell bodies are situated in the oculomotor complex of the midbrain and they do not seem to project to the median eminence and no fibres were detected in the hypothalamus (Mikami et al, 1988; Kuenzel and Blhaser, 1991 The MBH were maintained in oxygenated artificial avian cerebrospinal fluid (ACSF) on ice during collection. ACSF was prepared immediately prior to the experiment (for composition, see Knight, 1983) . Bacitracin (300 mg/I) was added to inhibit the activity of endogenous peptidase.
Static incubation system
One MBH was placed in each glass tube containing 500 wl ACSF. The tubes were incubated in a warmed (40°C) water-bath with shaking (50 cycles/min). Each tube was individually gassed with 95% 0 2 /5% C0 2 throughout the incubation.
A preincubation period of 1 h was observed to allow stabilisation of the basal release of GnRH. The incubation medium was collected and replaced with 500 pl fresh medium every 30 min without further washing of the tissue. Collected fractions were stored frozen at -20°C until cLHRH-I concentration was measured.
Production of antibody to cLHRH-I Synthetic C LHRH ([Gln8]) GnRH, Peninsula Laboratories Ltd, St Helens, Merseyside, UK) was conjugated with human serum albumin (HSA) using the carbodiimide method (Fraser et al, 1974) . Peptide (8 mg) was mixed with 91.6 mg HSA (Sigma) and 80 mg 3-(3-dimethylaminopropyl)carbodiimide (Sigma). After shaking for 7 h, the peptide-protein conjugate was separated by dialysis against 0.01% mercaptoethanol, with several changes, for 48 h.
Rabbits were immunized by intra-dermal injection with the cLHRH-i conjugate homogenized with complete Freund's adjuvant. Four successive injections were performed at 7-d intervals. An iv booster injection, using Phenergan! (promethazine) as anti-histaminic agent, was administered 4 weeks after the last injection and was followed by several booster injections at regular intervals. After a final booster injection, one antiserum (516/13) proved suitable for measurement of cLHRH-1 release in vitro.
Radioiodination of cLHRH-1 Synthetic cLHRH-1 was labelled with 125 1 using the iodogen method (Salacinski et al, 1979 Knight (1983) . Samples were incubated 24 h at 4°C in the presence of antiserum 516/13 at the final dilution of 1/180 000 (B/T = 35%). The labelled hormone (10 000 cpm/tube) was added on the 2nd day and tubes were incubated 48 h at 4°C. On the 4th day, the sheep anti-rabbit immunoglobulin was added with normal rabbit serum and polyethylene glycol.
After 45 min of incubation, the tubes were centrifuged, the supernatant aspirated and the radioactivity of the pellets counted with a gamma counter. The specificity, sensitivity and precision of the assay were determined.
Validation of the incubation system 
Effect of EAA on the release of cLHRH-I in vitro
The release of cLHRH-I was evaluated in the presence of 100 11M glutamate (GLU) and 100 11M Nmethyl-D-aspartate (NMDA). Two groups of 4 MBH were used. Two 30-min incubation periods were used. The basal release of cLHRH-1 was determined during the first incubation period and the effect of the 2 EAA in the second.
The effect of increasing doses (1 pM, 10 0 pM , 100 pM) of NMDA and kainic acid (KA) were studied. Two groups of 4 MBH were used. Fractions were collected every 30 min. The doses were applied at 1.5-h intervals. Each stimulation with EAA was preceded by a basal release fraction, and followed by a washing fraction which was not collected.
Statistical analysis
Within-treatment comparisons were performed by a paired t test and between treatment comparisons by a t test.
RESULTS

Validation of the radioimmunoassay for cLHRH-I
The study in our cLHRH-1 radioimmunoassay system, using antiserum 516/13, of the immunoreactivity of increasing concentrations of several hypothalamic peptides revealed 100% cross-reaction with mammalian LHRH and 20% cross-reaction with chicken LHRH-11. No cross-reaction could be detected with leucine-enkephalin, methionin-enkephalin, thyrotropin-releasing hormone (TRH) and corticotropin-releasing factor (CRF) up to a concentration of 10 0 pg/ml, ie between 1 and 10 pM. The dose that inhibited the binding of the radiolabelled hormone by 50% (ED 50 ) was 4.85 pg/tube, ie a concentration of 24.25 pg/ml. The limit of sensitivity of the assay, expressed as the dose that inhibited the binding of the radiolabelled hormone by 20% (ED 80 ) was 0.916 6 pg/tube, ie 4.58 pg/ml. The immunoreactivity of serial dilutions of hypothalamic extracts from cockerels proved parallel to the standard curve. The intra-and interassay coefficients of variation were, 4.4 and 10.2%, respectively.
Validation of the incubation system
The depolarization induced by 64 mM potassium elicited an 8-fold increase (P< 0.01) in cLHRH-I release (fig 1 The second depolarization occurring 2 h later induced an equivalent increase (P < 0.01 ) in the secretion of the peptide. Experiment 2 showed that the depolarization-induced release of cLHRH-I was dose-dependent (fig 2a) . Each concentration of potassium elicited a significant increase (compared with basal release) in the secretion (P < 0.05 for 32 mM and P < 0.01 for the other 3 concentrations). The omission of calcium ions in ACSF considerably reduced the 56 mM potassium-induced release of cLHRH-1. The 1.5-fold increase in the concentration observed in this group was not significant (fig 2b) .
Effect of EAA on the release of cLHRH-I in vitro Incubation of MBH in the presence of 100 pM GLU and 100 pM NMDA resulted in a 10-fold (P < 0.001 ) and a 4-fold (P < 0.01 ) increase in the release of cLHRH-I, respectively (fig 3) .
NMDA elicited a dose-related increase in the secretion of cLHRH-1 (fig 4a) . The first significant (P < 0.001) increase was obtained with the 10 pM dose, which multiplied the secretion by 4. The release elicited by the 100 pM dose was very pronounced and was increased more than 10-fold. The stimulation of the release of cLHRH-1 in the presence of KA also showed a dose-dependent profile (fig 4b) . The response was, however, of much lesser amplitude than that with NMDA, and the highest dose used (100 pM) only elicited a 2-fold increase in the secretion.
DISCUSSION
As no release of cLHRH-II could be detected by MBH in vitro (Katz et al, 1990 ; and our preliminary work), the 20% cross-reactivity of our assay with cLHRH-I I is not an obstacle to its use for in vitro experiments on chicken MBH. Furthermore, no cross-reactivity was found with the following other hypothalamic peptides: leu-and metenkephalin, TRH and CRF. Moreover, the high sensitivity of this assay makes it suitable for the measurement of cLHRH-1 in vitro.
The ability of incubated MBH to release cLHRH-I in response to a depolarization in a dose-dependent manner, and to respond to a second depolarization with a comparable magnitude, evidenced the good viability of the tissue in the incubation conditions used. Moreover, the necessity of the presence of calcium ions in the incubation medium for a response to occur showed that this release answers to the physiological mechanisms of neural secretion (Smith and Augustine, 1988 (Gay and Plant, 1987; Ondo et al, 1988) and agonists to stimulate the release of LHRH by hypothalamic tissue of rats in vitro (Bourguignon et al, 1989; Lopez et al, 1992 (1989) that NMDA is more potent than KA in eliciting the release of GnRH by incubated hypothalimi in the rat. However, the specificity of these effects in the chicken has to be further documented by the use of antagonists.
In conclusion, our static incubation system coupled to the radioimmunoassay proved to be suitable for the study of cLHRH-I release by cockerel MBH. We were thus able to bring first evidence of the stimulatory action of EAAs on the secretion of cLHRH-1 in the cockerel and hence of their possible involvement in the control of reproduction through modulation of LH release in this species.
